These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. (18)F-FDG PET/CT and MRI findings in a patient with anti-GABA(B) receptor encephalitis. Su M; Xu D; Tian R Clin Nucl Med; 2015 Jun; 40(6):515-7. PubMed ID: 25608169 [TBL] [Abstract][Full Text] [Related]
27. Serial brain ¹⁸FDG-PET in anti-AMPA receptor limbic encephalitis. Spatola M; Stojanova V; Prior JO; Dalmau J; Rossetti AO J Neuroimmunol; 2014 Jun; 271(1-2):53-5. PubMed ID: 24793897 [TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET/CT in Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis: Typical Pattern and Follow-up. Caquot PA; Zizi G; Lelièvre M; Dejust S; Morland D Clin Nucl Med; 2021 Mar; 46(3):250-251. PubMed ID: 33323741 [TBL] [Abstract][Full Text] [Related]
29. 18F-FDG PET/CT in anti-LGI1 encephalitis: initial and follow-up findings. Park S; Choi H; Cheon GJ; Wook Kang K; Lee DS Clin Nucl Med; 2015 Feb; 40(2):156-8. PubMed ID: 25140541 [TBL] [Abstract][Full Text] [Related]
31. Potential usefulness of 18F-2-fluoro-deoxy-D-glucose positron emission tomography in cervical compressive myelopathy. Baba H; Uchida K; Sadato N; Yonekura Y; Kamoto Y; Maezawa Y; Furusawa N; Abe Y Spine (Phila Pa 1976); 1999 Jul; 24(14):1449-54. PubMed ID: 10423790 [TBL] [Abstract][Full Text] [Related]
32. Tane S; Suri V; Ahuja A; Jena A Neurol India; 2022; 70(5):2183-2184. PubMed ID: 36352635 [No Abstract] [Full Text] [Related]
33. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Ances BM; Vitaliani R; Taylor RA; Liebeskind DS; Voloschin A; Houghton DJ; Galetta SL; Dichter M; Alavi A; Rosenfeld MR; Dalmau J Brain; 2005 Aug; 128(Pt 8):1764-77. PubMed ID: 15888538 [TBL] [Abstract][Full Text] [Related]
34. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346 [TBL] [Abstract][Full Text] [Related]
35. FDG-PET findings in patients with suspected encephalitis. Lee BY; Newberg AB; Liebeskind DS; Kung J; Alavi A Clin Nucl Med; 2004 Oct; 29(10):620-5. PubMed ID: 15365433 [TBL] [Abstract][Full Text] [Related]
36. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778 [TBL] [Abstract][Full Text] [Related]
37. Two different 18F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis. Fisher RE; Patel NR; Lai EC; Schulz PE Clin Nucl Med; 2012 Sep; 37(9):e213-8. PubMed ID: 22889795 [TBL] [Abstract][Full Text] [Related]
38. Planned ictal FDG PET imaging for localization of extratemporal epileptic foci. Meltzer CC; Adelson PD; Brenner RP; Crumrine PK; Van Cott A; Schiff DP; Townsend DW; Scheuer ML Epilepsia; 2000 Feb; 41(2):193-200. PubMed ID: 10691116 [TBL] [Abstract][Full Text] [Related]
39. Hypermetabolism of the medial temporal lobe in limbic encephalitis on (18)FDG-PET scan: a case report. Na DL; Hahm DS; Park JM; Kim SE Eur Neurol; 2001; 45(3):187-9. PubMed ID: 11306867 [No Abstract] [Full Text] [Related]